Irving Llibran Reyna-Rodríguez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Irving Llibran Reyna-Rodríguez has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Jorge Ocampo-Candiani
Department of Dermatology, Hospital Universitario “Dr. José Eleuterio González” Universidad Autónoma de Nuevo León Monterrey México
9 shared publications - Sonia Chavez-Alvarez
Dermatology Department, Hospital Universitario ‘Dr. José Eleuterio González’ Universidad Autónoma de Nuevo León Monterrey Mexico
6 shared publications - Ana Lizzeth Figueroa‐Morales
Dermatology Department Hospital Universitario “Dr. José Eleuterio González” Universidad Autónoma de Nuevo León Monterrey México
2 shared publications - David Emmanuel Kubelis‐López
Dermatology Department Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León Monterrey Mexico
2 shared publications - Erika Alba‐Rojas
Department of Dermatology Hospital Universitario “Dr. José Eleuterio González”, Universidad Autónoma de Nuevo León Monterrey Nuevo Leon Mexico
2 shared publications - Valeria F. Garza-Davila
Dermatology Department, Universidad Autonoma de Nuevo Leon, Facultad de Medicina y Hospital Universitario “Dr. José E. Gonzalez”, Monterrey, Mexico
2 shared publications
Latest Publications
- Open Access
- 1 March 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 99 (2) , 292-294
O carcinoma de células de Merkel está associado à exposição a doses elevadas e crônicas de arsênico?
- 1 March 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 99 (2) , 292-294
Open AccessO carcinoma de células de Merkel está associado à exposição a doses elevadas e crônicas de arsênico?
- Open Access
- 21 December 2023
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 99 (2) , 292-294
Is Merkel cell carcinoma associated with high and chronic arsenic dose exposure?
- 21 December 2023
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 99 (2) , 292-294
Open AccessIs Merkel cell carcinoma associated with high and chronic arsenic dose exposure?
- Open Access
- 1 May 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 96 (3) , 358-361
Caso para diagnóstico. Pápula normocrômica assintomática na região bucinadora
- 1 May 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 96 (3) , 358-361
Open AccessCaso para diagnóstico. Pápula normocrômica assintomática na região bucinadora
- Open Access
- 1 May 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 96 (3) , 358-361
Case for diagnosis. Infraorbital schwannoma
- 1 May 2021
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 96 (3) , 358-361
Open AccessCase for diagnosis. Infraorbital schwannoma
- 11 February 2021
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (9) , 3054-3056
Pigmented disseminated superficial actinic porokeratosis in dark‐skinned patients: Clinical, dermoscopic, and histopathologic features
Click on the article title to read more.
- 11 February 2021
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 20 (9) , 3054-3056
Pigmented disseminated superficial actinic porokeratosis in dark‐skinned patients: Clinical, dermoscopic, and histopathologic features
Click on the article title to read more.
- 12 January 2021
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 313 (10) , 815-827
Cryotherapy plus low-dose oral isotretinoin vs cryotherapy only for the treatment of anogenital warts: a randomized clinical trial
Background Anogenital warts are a common human papillomavirus infection. They cause emotional distress, especially when they are in the anogenital region. Cryotherapy is a first-line treatment. Previous clinical trials and case series have reported variable results with retinoids (isotretinoin) as adjuvant therapy. Objective To determine the safety and efficacy of low-dose oral isotretinoin as adjuvant treatment of anogenital warts. Methods Forty-six patients with anogenital warts were randomly assigned to isotretinoin + cryotherapy (n = 23) or only cryotherapy (n = 23). Patients were allocated via an interactive web-based randomization system. Evaluators were blinded to treatments. Isotretinoin 20 mg/daily + cryotherapy or cryotherapy were prescribed for 6 weeks. Patients were followed for 4 months. Genotyping of lesions was performed before treatment started. Dermatology Life Quality Index (DLQI) and Columbia-Suicide Severity Rating Scale (C-SSRS) were measured at the beginning and end of therapy. All patients completed the study. Results Both Groups had 50% clearance at the end of treatment. Recurrence in the combined group was not significantly lower than in the cryotherapy group (P = 0.59). Improvement was observed in the DLQI of all patients in both groups (P = 0.001). No suicidal intention was detected with the C-SSRS. Two patients (one in each group) had liver function test abnormalities after treatment. Conclusion Combined therapy showed a slight not significant efficacy for anogenital warts in Hispanic patients. Low-dose isotretinoin seems to be safe even when it is used with cryotherapy on anogenital warts. Trial registration On April 25, 2019 with registration number DE19-00004, CONBIOÉTICA-19-CEI-001–20160404. Prospectively registered.
- 12 January 2021
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 313 (10) , 815-827
Cryotherapy plus low-dose oral isotretinoin vs cryotherapy only for the treatment of anogenital warts: a randomized clinical trial
Background Anogenital warts are a common human papillomavirus infection. They cause emotional distress, especially when they are in the anogenital region. Cryotherapy is a first-line treatment. Previous clinical trials and case series have reported variable results with retinoids (isotretinoin) as adjuvant therapy. Objective To determine the safety and efficacy of low-dose oral isotretinoin as adjuvant treatment of anogenital warts. Methods Forty-six patients with anogenital warts were randomly assigned to isotretinoin + cryotherapy (n = 23) or only cryotherapy (n = 23). Patients were allocated via an interactive web-based randomization system. Evaluators were blinded to treatments. Isotretinoin 20 mg/daily + cryotherapy or cryotherapy were prescribed for 6 weeks. Patients were followed for 4 months. Genotyping of lesions was performed before treatment started. Dermatology Life Quality Index (DLQI) and Columbia-Suicide Severity Rating Scale (C-SSRS) were measured at the beginning and end of therapy. All patients completed the study. Results Both Groups had 50% clearance at the end of treatment. Recurrence in the combined group was not significantly lower than in the cryotherapy group (P = 0.59). Improvement was observed in the DLQI of all patients in both groups (P = 0.001). No suicidal intention was detected with the C-SSRS. Two patients (one in each group) had liver function test abnormalities after treatment. Conclusion Combined therapy showed a slight not significant efficacy for anogenital warts in Hispanic patients. Low-dose isotretinoin seems to be safe even when it is used with cryotherapy on anogenital warts. Trial registration On April 25, 2019 with registration number DE19-00004, CONBIOÉTICA-19-CEI-001–20160404. Prospectively registered.
- 22 November 2020
- Published by Wiley in Pediatric Dermatology
- Vol. 38 (1) , 327-328
Giant congenital fibroepithelial polyp of the scrotum
Fibroepithelial polyps are common tumors of mesodermal origin. However, only a few case reports of giant fibroepithelial polyps have been published, and they have mainly involved adults. This case report describes a 3‐month‐old boy with a pedunculated mass in the scrotum. To our knowledge, this is the first report of a giant congenital fibroepithelial polyp on this location.
- 22 November 2020
- Published by Wiley in Pediatric Dermatology
- Vol. 38 (1) , 327-328
Giant congenital fibroepithelial polyp of the scrotum
Fibroepithelial polyps are common tumors of mesodermal origin. However, only a few case reports of giant fibroepithelial polyps have been published, and they have mainly involved adults. This case report describes a 3‐month‐old boy with a pedunculated mass in the scrotum. To our knowledge, this is the first report of a giant congenital fibroepithelial polyp on this location.
- 1 November 2020
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 61 (4) , E458-E459
Bilateral plantar plaques in a patient with Keratitis-ichthyosis-deafness syndrome
- 1 November 2020
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 61 (4) , E458-E459
Bilateral plantar plaques in a patient with Keratitis-ichthyosis-deafness syndrome
- 15 June 2020
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 21 (5) , 681-696
Primary Cutaneous Coccidioidomycosis: An Update
Coccidioidomycosis is an endemic mycosis of the southern United States, Northern Mexico, and South America. Primary cutaneous coccidioidomycosis, despite being a very rare clinical presentation, has shown an increasing incidence. An extensive literature search for cutaneous coccidioidomycosis cases was performed using the OLDMEDLINE, PubMed, Cochrane, LILACS and Google Scholar databases for studies published from January 1927 through December 21, 2019. Forty-two observational studies were included totaling 82 cases of primary cutaneous coccidioidomycosis. Narrative reviews, systematic reviews, and meta-analyses were also included. Additionally, an original case was included. Patients with primary cutaneous coccidioidomycosis share the same geographical and epidemiological characteristics as those with pulmonary or disseminated coccidioidomycosis. Most of the imported cases came from endemic areas. A large portion of cases had prior local skin trauma. Tissue culture is still the leading diagnostic method; nevertheless, molecular techniques such as polymerase chain reaction (PCR) are currently relevant to differentiate between species. First-line treatment consists of azoles; however, it has an excellent prognosis even without treatment. Primary cutaneous coccidioidomycosis should be considered a differential diagnosis of unusual infections or neoformations in any part of the body in resident populations of endemic areas or in patients with a previous history of travel to these areas.
- 15 June 2020
- Published by Springer Nature in American Journal of Clinical Dermatology
- Vol. 21 (5) , 681-696
Primary Cutaneous Coccidioidomycosis: An Update
Coccidioidomycosis is an endemic mycosis of the southern United States, Northern Mexico, and South America. Primary cutaneous coccidioidomycosis, despite being a very rare clinical presentation, has shown an increasing incidence. An extensive literature search for cutaneous coccidioidomycosis cases was performed using the OLDMEDLINE, PubMed, Cochrane, LILACS and Google Scholar databases for studies published from January 1927 through December 21, 2019. Forty-two observational studies were included totaling 82 cases of primary cutaneous coccidioidomycosis. Narrative reviews, systematic reviews, and meta-analyses were also included. Additionally, an original case was included. Patients with primary cutaneous coccidioidomycosis share the same geographical and epidemiological characteristics as those with pulmonary or disseminated coccidioidomycosis. Most of the imported cases came from endemic areas. A large portion of cases had prior local skin trauma. Tissue culture is still the leading diagnostic method; nevertheless, molecular techniques such as polymerase chain reaction (PCR) are currently relevant to differentiate between species. First-line treatment consists of azoles; however, it has an excellent prognosis even without treatment. Primary cutaneous coccidioidomycosis should be considered a differential diagnosis of unusual infections or neoformations in any part of the body in resident populations of endemic areas or in patients with a previous history of travel to these areas.